Rejo P. Cherian, M.D., Joins Marcus Neuroscience Institute as a Neurologist

• by

• July 9, 2026

FDA approves first therapy for Alexander disease

The antisense oligonucleotide reduces production of the abnormal protein that accumulates in supportive cells in the brain.

• by Kathryn Wighton

• September 4, 2026

• 2 min

Symptom Scores May Signal Neuropathy Risk

Early recovery symptom patterns may help clinicians identify which oropharyngeal cancer survivors warrant closer neurologic surveillance.

• by Andrea Surnit

• May 6, 2026

• 4 min

Utilizing Augmented Reality in Physiotherapy Rehabilitation During the Initial Stage of Guillain-Barré Syndrome: A Case Study

• by Rushika shah, Snehal Samal

• February 2, 2026